Since E. coli is a common colonizer of the normal gut microbiota, increasing prevalence of ESBL-producing strains is particularly worrisome. Once disseminated in the community, containment of this resistance type will be challenging. The driver of ESBL-producing Enterobacteriaceae (EPE) is debated. ...
[8]Ten Doesschate T, Kuiper S, van Nieuwkoop C, et al. Fosfomycin Vs Ciprofloxacin as Oral Step-Down Treatment for Escherichia coli Febrile Urinary Tract Infections in Women: A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial. Clin Infect Dis. 2022;75(2):221-229. doi:10.109...
[8]Ten Doesschate T, Kuiper S, van Nieuwkoop C, et al. Fosfomycin Vs Ciprofloxacin as Oral Step-Down Treatment for Escherichia coli Febrile Urinary Tract Infections in Women: A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial. Clin Infect Dis. 2022;75(2):221-229. doi:10.109...
8. Malaisri C, Phuphuakrat A, Wibulpolprasert A, et al. A randomized controlled trial of sitafloxacin vs. ertapenem as a switch?therapy after treatment for acute pyelonephritis caused by extended-spectrum β-lactamase-producing Escherichi...
45744581产ESBLs菌株血行感染:头孢菌素的经验性治疗疗效判断与MIC的相关性Bloodstream Infections Due to Extended-SpectrumBeta-Lactamase-Producing Escherichia coli and Klebsiella pneumo 20、niae:Risk Factors for Mortality and Treatment Outcome, with SpecialEmphasis on Antimicrobial Therapy. AAC. 2004, 48,(12)...
Production of these enzymes in clinical infections can result in treatment failure if one of the second or third generation cephalosporins is used. This study investigates the incidence of ESBL among E. coli and K. pneumoniae which were isolated from tuberculosis patients with secondary opportunistic ...
[8]Ten Doesschate T, Kuiper S, van Nieuwkoop C, et al. Fosfomycin Vs Ciprofloxacin as Oral Step-Down Treatment for Escherichia coli Febrile Urinary Tract Infections in Women: A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial. Clin Infect Dis. 2022;75(2):221-229. doi:10.109...
产ESBLs肠杆菌科细菌感染以及治疗 社区革兰阴性菌感染肠杆菌科细菌 2%1%1%2%4%6% 8% >70% 46% E.coli Klebsiellaspp.Pseudomonasaeruginosa Enterobacterspp.,Serratiaspp.,andCitrobacterspp.Acinetobacterspp.Proteusmirabilis Indole-positiveProteusspp.13% Othernonfermenters Stenotrophomonasmaltophilia 17% Others Antimic...
2003. Extended Spectrum β- Lactamase (ESBL)-producing Enterobacteriaceae: Considerations for diagnosis, prevention and drug treatment. Drugs. 63: 353-365... DME Rupp,PD Fey - 《Drugs》 被引量: 141发表: 2003年 Extended-Spectrum β-Lactamase (ESBL)–Producing Enterobacteriaceae: A Threat from the...
超广谱b-内酰胺酶(ESBL)是能水解头孢噻肟，头孢他 啶，头孢三嗪等第三代头孢菌素及氨曲南等单环类抗 生素，并介导细菌对这些抗生素耐药的b-内酰胺酶 超广谱b-内酰胺酶（ESBLs）是TEM-1/2或SHV-1经过1～4个氨基酸的突变而形成的 所有ESBLS其编码基因都在质粒上，DNA大小不等，23kbs~100...